XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Ward Village Homeowners Associations
Total Stockholders' Equity
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Noncontrolling Interests
Noncontrolling Interests
Ward Village Homeowners Associations
Balance at the beginning of the period (in shares) at Dec. 31, 2021       56,173,276            
Balance at the beginning of the period at Dec. 31, 2021 $ 3,710,670   $ 3,709,995 $ 563 $ 3,960,418 $ (16,456) $ (14,457) $ (220,073) $ 675  
Balance at the beginning of the period (in shares) at Dec. 31, 2021               (2,107,615)    
Increase (Decrease) in Stockholders' Equity                    
Net income (loss) 23,603   23,686     23,686     (83)  
Interest rate swaps, net of tax 23,542 [1]   23,542       23,542      
Deconsolidation of Ward Village homeowners’ associations   $ (210)               $ (210)
Teravalis noncontrolling interest 50,021               50,021  
Reclassification of the Company’s share of previously deferred derivative gains, net of tax expense [2] (6,723)   (6,723)       (6,723)      
Repurchase of common shares (in shares)               (3,915,068)    
Repurchase of common shares (362,932)   (362,932)         $ (362,932)    
Stock plan activity (in shares)       122,272       (10,316)    
Stock plan activity 5,830   5,830 $ 1 6,776     $ (947)    
Balance at the end of the period (in shares) at Jun. 30, 2022       56,295,548            
Balance at the end of the period at Jun. 30, 2022 3,443,801   3,393,398 $ 564 3,967,194 7,230 2,362 $ (583,952) 50,403  
Balance at the end of the period (in shares) at Jun. 30, 2022               (6,032,999)    
Balance at the beginning of the period (in shares) at Mar. 31, 2022       56,300,324            
Balance at the beginning of the period at Mar. 31, 2022 3,553,398   3,552,884 $ 564 3,964,412 (14,334) (6,103) $ (391,655) 514  
Balance at the beginning of the period (in shares) at Mar. 31, 2022               (3,868,215)    
Increase (Decrease) in Stockholders' Equity                    
Net income (loss) 21,432   21,564     21,564     (132)  
Interest rate swaps, net of tax 8,465 [1]   8,465       8,465      
Teravalis noncontrolling interest 50,021               50,021  
Repurchase of common shares (in shares)               (2,164,400)    
Repurchase of common shares (192,262)   (192,262)         $ (192,262)    
Stock plan activity (in shares)       (4,776)       (384)    
Stock plan activity 2,747   2,747   2,782     $ (35)    
Balance at the end of the period (in shares) at Jun. 30, 2022       56,295,548            
Balance at the end of the period at Jun. 30, 2022 $ 3,443,801   3,393,398 $ 564 3,967,194 7,230 2,362 $ (583,952) 50,403  
Balance at the end of the period (in shares) at Jun. 30, 2022               (6,032,999)    
Balance at the beginning of the period (in shares) at Dec. 31, 2022 49,801,997     56,226,273            
Balance at the beginning of the period at Dec. 31, 2022 $ 3,606,112   3,540,499 $ 564 3,972,561 168,077 10,335 $ (611,038) 65,613  
Balance at the beginning of the period (in shares) at Dec. 31, 2022 (6,424,276)             (6,424,276)    
Increase (Decrease) in Stockholders' Equity                    
Net income (loss) $ (41,768)   (41,888)     (41,888)     120  
Interest rate swaps, net of tax (2,582) [1]   (2,582)       (2,582)      
Teravalis noncontrolling interest 117               117  
Stock plan activity (in shares)       306,757       (20,472)    
Stock plan activity 6,596   6,596 $ 2 8,219     $ (1,625)    
Other $ (22)               (22)  
Balance at the end of the period (in shares) at Jun. 30, 2023 50,088,282     56,533,030            
Balance at the end of the period at Jun. 30, 2023 $ 3,568,453   3,502,625 $ 566 3,980,780 126,189 7,753 $ (612,663) 65,828  
Balance at the end of the period (in shares) at Jun. 30, 2023 (6,444,748)             (6,444,748)    
Balance at the beginning of the period (in shares) at Mar. 31, 2023       56,427,928            
Balance at the beginning of the period at Mar. 31, 2023 $ 3,582,523   3,516,758 $ 566 3,977,514 145,332 5,005 $ (611,659) 65,765  
Balance at the beginning of the period (in shares) at Mar. 31, 2023               (6,431,442)    
Increase (Decrease) in Stockholders' Equity                    
Net income (loss) (19,141)   (19,143)     (19,143)     2  
Interest rate swaps, net of tax 2,748 [1]   2,748       2,748      
Teravalis noncontrolling interest 61               61  
Stock plan activity (in shares)       105,102       (13,306)    
Stock plan activity $ 2,262   2,262   3,266     $ (1,004)    
Balance at the end of the period (in shares) at Jun. 30, 2023 50,088,282     56,533,030            
Balance at the end of the period at Jun. 30, 2023 $ 3,568,453   $ 3,502,625 $ 566 $ 3,980,780 $ 126,189 $ 7,753 $ (612,663) $ 65,828  
Balance at the end of the period (in shares) at Jun. 30, 2023 (6,444,748)             (6,444,748)    
[1] Amounts are shown net of tax expense of $0.8 million for the three months ended June 30, 2023, tax benefit of $0.8 million for the six months ended June 30, 2023, and tax expense of $2.5 million for the three months ended June 30, 2022, and $7.0 million for the six months ended June 30, 2022.
[2] In March 2022, the Company completed the sale of its ownership interest in 110 North Wacker and released a net of $6.7 million from Accumulated other comprehensive income (loss), representing the Company’s $8.6 million share of previously deferred gains associated with the Venture’s derivative instruments net of tax expense of $1.9 million. See Note 2 - Investments in Unconsolidated Ventures for additional information.